Latest filing published 29 Sept 2017 for Hiscox Ltd, €27k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +27.7%Entry £12.97 · Close at T+365 £16.56
- +18.4%Entry £12.76 · Close at T+365 £15.11
- +32.2%Entry £11.02 · Close at T+365 £14.57
- +44.4%Entry £9.82 · Close at T+365 £14.18
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ernst Jansen: trading record in brief
Ernst Jansen discloses dealings in Hiscox Ltd to RNS (LSE). The record holds 4 filings, for trades running from 14 December 2016 to 29 September 2017.
On the market, this insider has only ever bought: 4 purchases, €112k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2017, the count stands at 3 purchases and no sales.
Half of the purchases are above €28k and half below. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 75% of cases, with a median move of +11.0%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 29 September 2017, reports an open-market purchase of €27k in Hiscox Ltd. Publication is fast: at least half of the trades appear on RNS (LSE) on the same day. The legal deadline for notifying a trade is three business days (UK MAR). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ernst Jansen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,839 shares@ £12.804132.4% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20170929151415_13381026_20200330131541219_21844-0Canonical exit: 28 Dec 2017 (T+90)
- 1,926 shares@ £12.484533.0% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20170614155700_13260686_20200330131522370_11551-0Canonical exit: 12 Sept 2017 (T+90)
- 2,241 shares@ £11.024725.8% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20170330162043_13177705_20200330131526808_24914-0Canonical exit: 28 Jun 2017 (T+90)
- 2,407 shares@ £10.035134.7% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20161215170447_013069002_20200330143549225_11841-0Canonical exit: 14 Mar 2017 (T+90)
4 of 4 declarations